Research Study for People Getting an ICD

Study Summary

The University of Chicago and Dr. Beshai are conducting a study to learn more about the long term performance of a family of cardiac resynchronization therapy defibrillator (CRT-D) devices or implantable cardioverter defibrillator (ICD) devices, as well as a newly marketed right ventricular lead. The devices used in this study are approved by the Food and Drug Administration (FDA). This study is required by the FDA to gain additional data about the devices and lead.

Benefits

There may be no benefit to you for participating in this study. However, the information obtained through this study will add to the overall knowledge of the long-term performance of the device system.

Participation Details

Initial selection criteria include:

• Must be scheduled for an ICD or CRT-D system implant for the treatment of heart failure or life-threatening ventricular tachyarrhythmia(s)
• Must be at least 18 years of age
• Must be available for clinic visits (every six months) for the duration of the study, which is five years
• Must meet study medical criteria as evaluated by Dr. Beshai

Study Director: Dr. John F. Beshai
Department: Cardiology

For more information contact:
Melissa Byrn
mbyrn@medicine.bsd.uchicago.edu
(773) 834-7157
IRB:#09-040-B